RIGL (STOCKS)
Rigel Pharmaceuticals Inc. (New)
$40.790000
-1.080000 (-2.58%)
Prev close: $41.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raul R. Rodriguez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $851.92M
- Employees
- 164
- P/E (TTM)
- 2.57
- P/B (TTM)
- 1.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.88 | $0.63 | +0.2476 | +39.15% |
|
Mar 2026 (Q1)
|
$0.44 | $0.78 | -0.3352 | -43.24% |
|
Dec 2025 (Q4)
|
$1.15 | $1.27 | -0.1217 | -9.57% |
|
Sep 2025 (Q3)
|
$1.46 | $0.87 | +0.5882 | +67.47% |
Financial Statements
| Revenues | $276.79M |
| Benefits Costs and Expenses | $191.21M |
| Cost Of Revenue | $23.84M |
| Costs And Expenses | $189.74M |
| Gross Profit | $252.95M |
| Operating Expenses | $165.90M |
| Selling, General, and Administrative Expenses | $122.22M |
| Research and Development | $43.68M |
| Operating Income/Loss | $87.05M |
| Income/Loss From Continuing Operations After Tax | $321.91M |
| Income/Loss From Continuing Operations Before Tax | $85.58M |
| Income Tax Expense/Benefit | -$236.33M |
| Net Income/Loss | $321.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $321.91M |
| Net Income/Loss Available To Common Stockholders, Basic | $321.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $17.83 |
| Diluted Earnings Per Share | $16.88 |
| Basic Average Shares | 36,590,000 |
| Diluted Average Shares | 39,236,000 |
| Assets | $521.07M |
| Current Assets | $185.53M |
| Cash | $95.39M |
| Inventory | $14.37M |
| Other Current Assets | $75.78M |
| Noncurrent Assets | $335.54M |
| Liabilities | $95.64M |
| Current Liabilities | $95.59M |
| Accounts Payable | $4.01M |
| Wages | $8.61M |
| Other Current Liabilities | $82.96M |
| Noncurrent Liabilities | $58.00K |
| Equity | $425.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $425.42M |
| Liabilities And Equity | $521.07M |
| Net Cash Flow From Operating Activities | $79.39M |
| Net Cash Flow From Operating Activities, Continuing | $79.39M |
| Net Cash Flow From Investing Activities | -$49.06M |
| Net Cash Flow From Investing Activities, Continuing | -$49.06M |
| Net Cash Flow From Financing Activities | -$22.92M |
| Net Cash Flow From Financing Activities, Continuing | -$22.92M |
| Net Cash Flow | $7.41M |
| Net Cash Flow, Continuing | $7.41M |
| Comprehensive Income/Loss | $322.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $321.76M |
| Other Comprehensive Income/Loss | $45.35M |